The .asia top-level domain is the regional registry for the Asia-Pacific community. Before sharing sensitive information, make sure you’re on a regional research site.
Tag: MEDICINE
-
Japan’s Emergency Contraception Retail Pilot Enters Second Week of Operation
Japan’s Emergency Contraception Retail Pilot Enters Second Week of Operation
Following the landmark February 2 launch, over 5,000 pharmacies nationwide continue to provide over-the-counter access to the morning-after pill.
Retail sales of NorLevo began earlier this month, marking a pivotal shift in Japan’s approach to reproductive healthcare.
Table of Contents
Retail Rollout Progress
It has been over a week since Japan officially authorized the over-the-counter (OTC) sale of NorLevo, an emergency contraceptive marketed by Daiichi Sankyo Healthcare. As of mid-February, the medication remains available at approximately 5,400 pharmacies, priced at ¥7,480 per dose.
The program aims to bridge the gap for those unable to visit a clinic within the critical 72-hour window following unprotected intercourse, where the drug maintains roughly 80% effectiveness in preventing pregnancy.
The Pharmacist’s Role
Unlike standard OTC medications, the morning-after pill requires a mandatory consultation. Purchasers must take the pill on-site in the presence of a trained pharmacist. This regulation ensures patients receive accurate information regarding potential side effects and future contraceptive planning.
Major chains like Welcia Pharmacy have reported that nearly all of their 7,200 pharmacists have completed the specialized training required by the health ministry to handle these sensitive consultations.
Privacy & Support Measures
To address concerns regarding social stigma, pharmacies have implemented “point-and-check” sheets and numerical coding systems so that customers do not have to announce the medication name out loud. Consultations are conducted at partitioned counters to ensure maximum privacy.
Crucially, pharmacists are now part of a coordinated network with local obstetricians. If a customer is suspected of having experienced sexual violence, pharmacies are equipped to provide immediate referrals to medical professionals and specialized support centers.
Ongoing Accessibility Challenges
While health experts like Dr. Ruriko Tsushima describe the move as long overdue, advocacy groups like Pilcon continue to lobby for further improvements. Primary concerns include the high out-of-pocket cost and the lack of 24-hour availability in rural areas where dispensing pharmacies may not have trained staff on night shifts.
As the pilot continues through 2026, the health ministry is expected to monitor sales data and patient feedback to determine if the program should be expanded to include more locations and more affordable pricing tiers.
Article Metadata
- Release Date: February 11, 2026
- Data Source: Health Ministry (Japan) & Jiji Press
- Organization: Health Science & Innovation Lab
-
Japan to Tighten Control on OTC Medications; Eight Ingredients Now Flagged for Abuse Risk
Japan to Tighten Control on OTC Medications; Eight Ingredients Now Flagged for Abuse Risk
The Ministry of Health, Labour and Welfare expands its list of regulated substances to curb the rising trend of teenage overdoses from cough and allergy medicines.
Japan is revising its pharmaceutical laws to combat the misuse of common over-the-counter (OTC) drugs among the youth population.
Table of Contents
In a proactive move to address the growing public health crisis of pharmaceutical misuse, Japan’s health ministry has announced the addition of two key ingredients to its official “abuse potential” list. This update, finalized by a ministry subcommittee on Friday, brings the total number of monitored substances in common medicines from six to eight.
The new additions include **dextromethorphan**, a cough suppressant (antitussive) widely found in cold remedies, and **diphenhydramine**, an antihistamine frequently used for allergies and sleep aids. These substances have been identified as primary drivers in the surge of intentional overdoses reported across the country.
The Revised Pharmaceutical and Medical Device Law
This regulatory shift is not merely a guideline but a formal integration into Japanese law. Effective **May 2026**, the revised Pharmaceutical and Medical Device Law will codify these restrictions, transitioning them from administrative ordinances to statutory requirements.
According to analysis by Dr. Titus, this legal upgrade empowers authorities to enforce sales monitoring more strictly, ensuring that pharmacies and retailers are held accountable for dispensing high-risk products.
Stricter Protections for Minors
A central pillar of the new regulation focuses on protecting the most vulnerable demographic: individuals under the age of 18. The upcoming measures include:
- Purchase Limits: Minors will be restricted to buying only a single, small-volume package of products containing the designated ingredients.
- Supply Constraints: Each individual sale will be limited to a supply intended for only five to seven days of use.
- Identity Verification: Retailers will be required to exercise greater diligence in verifying the age and intent of young purchasers.
The official public announcement of these designations is expected in mid-February, allowing the pharmaceutical industry and retail sector a brief window to prepare for the May enforcement deadline.
References
- The Japan Times. “Japan to designate eight ingredients for list of drugs with abuse risk.” Published Jan 25, 2026. Available from: Official Source
- Ministry of Health, Labour and Welfare (MHLW). Subcommittee Report on Over-the-Counter Medicine Misuse. (2026).
LEAVE A REPLY
Your email address will not be published. Required fields are marked *
LEAVE A REPLY
Your email address will not be published. Required fields are marked *